Rocket Pharmaceuticals Inc. (RCKT)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 866 |
| % of all portfolios: | 0.001% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
15 |
$707,502 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 06 Jan 2026 |
BJORK ELISABETH |
Director |
02 Jan 2026 |
10,000 |
3.44 |
34,400 |
| 27 Aug 2025 |
BJORK ELISABETH |
Director |
27 Aug 2025 |
10,000 |
3.41 |
34,100 |
| 14 Apr 2025 |
SHAH GAURAV |
CEO |
10 Apr 2025 |
20,000 |
5.08 |
101,600 |
| 10 Apr 2025 |
PATEL KINNARI |
See Remarks |
09 Apr 2025 |
21,099 |
4.70 |
99,165 |
| 11 Oct 2022 |
RTW INVESTMENTS, LP |
Director , 10% |
06 Oct 2022 |
1,355,932 |
14.75 |
19,999,997 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock